GSS 0.74% 68.0¢ genetic signatures limited

Can anyone explain the difference between sales revenue and cash...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 122 Posts.
    lightbulb Created with Sketch. 13
    Can anyone explain the difference between sales revenue and cash receipts?
    I thought this was a good result (with the former up 9% on corresponding period). It shouldn't be too long before we're profitable, especially with the new test kits being launched. This should have a snowball effect, with labs are more likely to choose our products, if we have multiple ones on offer.
    At any rate, a steadily expanding business is always an good investment providing its reasonably priced.
    But then cash receipts are down on the corresponding period, so perhaps I'm missing something (admittedly finance isn't my strong suit - I come from the healthcare vantage point).
    That final trade looks strange don't you think? $500 worth of shares just before 4 pm at a much lower price. Looks like weird computer trading to me.
 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
(20min delay)
Last
68.0¢
Change
0.005(0.74%)
Mkt cap ! $155.4M
Open High Low Value Volume
70.0¢ 70.0¢ 67.5¢ $16.68K 24.27K

Buyers (Bids)

No. Vol. Price($)
2 27724 67.5¢
 

Sellers (Offers)

Price($) Vol. No.
70.0¢ 15574 2
View Market Depth
Last trade - 14.24pm 03/12/2024 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.